MIRA Pharmaceuticals, Inc.MIRANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-5.56M
↓ 62% below average
Average (4y)
$-3.43M
Historical baseline
Range
High:$-67990.00
Low:$-5.60M
CAGR
+200.7%
Consistent expansion
PeriodValueChange
2024$-5.56M-22.7%
2023$-4.53M+19.1%
2022$-5.60M-307.3%
2021$-1.38M-1924.1%
2020$-67990.00-